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Circulating immune complexes trigger type I interferons exacerbating disease in systemic lupus erythema-
tosus. In this issue of Immunity, Henault et al. (2012) show that Fcg-receptor, Toll-like receptor 9, and LC3
conspire to mold phagosomes into type I interferon signaling platforms.Critical to determining the course and
consequence of phagocytosis is the
nature of the receptor-ligand interactions
at the phagocyte surface when cargo
makes contact. Engagement of surface
Toll-like receptors (TLRs) such as TLR4
initiates an inducible rate of phagocytosis
with faster kinetics of phagosome fusion
with lysosomes, and autonomous to
phagosomes carrying TLR ligands, tailor-
ing those phagosomes for optimal
antigen presentation functions. As phago-
cytosed cargo is degraded, exposed
ligands engage additional receptors,
whereby the collective signaling during
phagocytosis now accurately determines
the threat level encountered and coordi-
nates the appropriate immune response
(reviewed in Underhill and Goodridge
[2012]).
The maturing phagosome can also
intersect with the autophagy pathway.
Phagosomes containing TLR ligands
acquire microtubule-associated protein
1 light chain 3 (LC3), an event that facil-
itates fusion of phagosomes with lyso-
somes (Sanjuan et al., 2007). Phago-
somes carrying apoptotic cells could
also recruit LC3, demonstrating that
convergence of phagocytosis with the
autophagy pathway was not unique to
phagosomes carrying microorganisms
(Florey et al., 2011; Martinez et al.,
2011). There are key differences,
however, between this process and
conventional autophagy in that the auto-
phagosomal preinitiation machinery
(ULK1-FIP200-ATG13) is not involved
but rather the single phagosomal
membrane appears to serve as the
scaffold for LC3 recruitment, which
similar to its recruitment in conventional
autophagy, requires activity of the class
III phosphatidylinositol-3-kinase (PI3K)
VPS34, ATG5, and ATG7. These events
are distinguished from conventionalautophagy by the term ‘‘LC3-associated
phagocytosis’’ (LAP).
In this issue of Immunity, Henault
et al. (2012) discover that LAP enables
interferon-a (IFN-a) production by plas-
macytoid dendritic cells (pDC) and
macrophages in response to phagocy-
tosed large DNA-immune complexes
(DNA-IC), which they modeled in vitro by
conjugating beads with both anti-DNA
and DNA rich in immunostimulatory CpG
motifs (CpG-DNA). Inhibition of PI3K
activity or deficiency in ATG5 or ATG7
abrogated LC3 recruitment and, impor-
tantly, specifically halted IFN-a produc-
tion without affecting NF-kB-dependent
TNF-a production. These results demon-
strate the critical impact of LAP on the
functional consequences of phagocytosis
of DNA-IC. The response to free multi-
meric A-type CpG DNA (CpG-A), which
is a good inducer of IFN-a in pDC due to
its retention in specialized early endo-
somes (Honda et al., 2005), was not
affected. These findings increase our
understanding of the biology behind the
pathogenic activity of DNA-IC and the
heightened type I IFN production in
patients with systemic lupus erythemato-
sus (SLE) (Elkon and Santer, 2012). A
genome wide association study has
linked single nucleotide polymorphisms
in Atg5 with increased susceptibility to
SLE (Harley et al., 2008), a finding which
along with the authors’ results, prompted
their suggestion that targeting LAP
may present novel therapeutic strategies
for SLE.
Experiments with both pDC and
human peripheral blood mononuclear
cells showed that IFN-a production in
response to DNA-IC, formed this time by
complexing double-stranded CpG-rich
DNA with DNA antibody, depended on
the presence of the antibody and Fcg-
receptor (FcgR) engagement. WhereasImmunity 37, Dthe response to both these DNA-IC and
CpG-A required TLR9-MyD88 signaling,
the response to DNA-IC also required
FcgR engagement. Although it is not clear
whether these particular preparations of
DNA-IC are internalized by phagocytosis
or endocytosis, either way, the results
strongly suggest a previously unappreci-
ated form of communication between
surface FcgR and intracellular TLR9 in
the recognition of DNA-IC. Confocal
imaging in murine macrophages and
pDC shed some light on the nature of
this interplay revealing that TLR9 and its
endoplasmic reticulum (ER) chaperone
UNC93B were recruited to phagosomes
only when FcgRwas engaged, regardless
of whether those phagosomes carried the
TLR9 ligand or not. In fact, beads conju-
gated to CpG-DNA alone failed to recruit
TLR9 and UNC93B and behaved similarly
to inert unconjugated beads. In contrast,
endocytosed CpG-A promptly colocal-
ized with TLR9 and UNC93B.
Like TLR9, LC3 failed to decorate
phagosomes carrying inert or CpG-DNA
conjugated beads and was enriched
only around phagosomes carrying beads
conjugated to antibody alone or DNA-IC.
Using antibody-opsonized RBCs, the
authors show phagosomal LC3 colocali-
zation with TLR9. It thus appeared that
trafficking of TLR9 and LC3 were con-
trolled by engagement of FcgR. Indeed,
FcgR was critical as silencing FcgR
abrogated LC3 and TLR9 recruitment to
phagosomes carrying DNA-IC. Notably,
TLR9 signaling was dispensable for
LC3 recruitment to phagosomes, which
proceeded normally in TLR9 deficient
cells as long as the phagocytic cargo
engaged FcgR. TLR9 recruitment was
intact in ATG5 and ATG7 deficient cells
indicating that LAP was not responsible
for delivering TLR9 to phagosomes.
Thus, TLR9 and LC3 trafficked toecember 14, 2012 ª2012 Elsevier Inc. 947
Figure 1. Intracellular Pathways Leading to a Type I IFN Signaling Compartment
Depending on phagocytosis or endocytosis, LC3 and AP3, respectively, are differentially involved in preparing a type I IFN signaling IRF7 compartment. ‘‘IRF7
phagolysosomes’’ (left) are formed when FcgR signals recruit LC3 and ER TLR9-UNC93B to phagosomes carrying DNA-IC of large molecular size. pDC retain
endocytosed A-typeCpG-DNA (CpG-A) in TLR9+ ‘‘IRF7 endosomes’’ (right), whereas FcgR-mediated endocytosis of small DNA-ICmay also require FcgR signals
to recruit TLR9-UNC93B and AP3 for delivery to the ‘‘IRF7 endosome.’’ Although the IRF7 compartment requires two checkpoints in the form of TLR9 and LC3 or
AP3 recruitment, TLR9 recruitment is the only checkpoint for formation of the NF-kB compartment that signals NF-kB-dependent inflammatory cytokine
production.
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another, but always in this case in
response to FcgR engagement. The
surprising picture that emerges is that
engagement of FcgR during phagocy-
tosis controls TLR9 and LC3 recruitment
via distinct pathways. The nature of these
pathways is presently unclear.
So why is LAP important for mediating
the TLR9-dependent IFN-a response to
phagocytosed DNA-IC? In line with their
previous report that LAP facilitates phag-
olysosomal fusion (Sanjuan et al., 2007),
Henault et al. (2012) show that deficiency
in ATG7 impaired acquisition of the lyso-
somal protein LAMP-1 by DNA-IC con-
taining phagosomes, and this directly
impacted TLR9-dependent nuclear trans-
location of interferon regulatory factor 7
(IRF7), which mediates the IFN-a
response. LAMP-1 acquisition was inde-
pendent of intracellular TLR9-MyD88
signaling but depended on FcgR engage-
ment, demonstrating again the foremost
control exerted on phagosome matura-
tion by receptor-ligand interactions en-
gaged at the cell surface.
The authors’ findings were reminiscent
of data showing that the endosomal948 Immunity 37, December 14, 2012 ª2012adaptor protein AP3 binds to cleaved
endosomal TLR9 after stimulation with
CpG-A, promoting its localization to
acidic LAMP-2+ lysosome-related organ-
elles (LRO) (Sasai et al., 2010). There,
AP3 mediates the association of tumor
necrosis factor receptor associated factor
3 (TRAF3), which links MyD88 in this case
to activation of downstream kinases
important for IRF7 activation (Sasai
et al., 2010). Naturally, Henault et al.
(2012) investigated whether AP3 was
also involved in the IFN-a response to
their phagocytosed DNA-IC and surpris-
ingly found that it played no role. Using
TRAF3 fused to a PI(3,5)P2-binding plex-
trin homology (PH) domain, the authors
targeted TRAF3 to DNA-IC containing
phagosomes and could successfully
reconstitute the ability of TLR9 to signal
the IFN-a response in ATG7-deficient
pDC.
In the course of their study, Henault
et al. (2012) made a number of observa-
tions that together with work from the
laboratories of Iwasaki and Taniguchi
(Sasai et al., [2010]; Honda et al. [2005])
reveal fundamental differences in the traf-
ficking to TLR9 in response to the deliveryElsevier Inc.of its ligand via the endocytic versus
phagocytic pathway. Upon endocytosis
of CpG-A, AP3 delivers TLR9 from an
early endosome to a LRO where retention
of CpG-A dictates generation of an IRF7-
dependent IFN-a response (Honda et al.,
2005; Sasai et al., 2010). pDC may be
naturally equipped with a LRO dedicated
for type I IFN production, an ‘‘IRF7 endo-
some’’ where endocytosed CpG-A traf-
fics to, a property that could only be
achieved in other DC, and macrophages
when CpG-A is complexed to cationic
liposomes (Honda et al., 2005). Henault
et al. (2012) show that upon phagocytosis
of DNA-IC, FcgR signaling recruits
both TLR9 and LC3 to phagosomes and
LC3 ensures fusion of the phagosome
with a LRO competent for IRF7-IFN-a
signaling, an ‘‘IRF7 phagolysosome’’
(Figure 1). It is important to note here
that segregation of DNA-IC into FcgR-
dependent phagocytosis versus endocy-
tosis will ultimately be determined by the
molecular size of DNA-IC and may influ-
ence the differential involvement of LC3
versus AP3, respectively, in generation
of type I IFN signaling compartments.
This idea needs rigorous testing. Further
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circulating DNA-IC in patients can engage
LAP. Immune complexes of both large
and small size are found in lupus patients
and which appear to be associated with
different clinical manifestations (Tung
et al., 1981). Thus, dual targeting of LAP
and AP3may be therapeutically important
in SLE.
Of note, engagement of the receptor
TIM-4 by phosphatidyl serine (PS) on
apoptotic cells is critical for LC3 recruit-
ment (Martinez et al., 2011). Therefore,
LAP requires that a ligand-receptor
interaction take place at the plasmamem-
brane as shown so far following LPS-
TLR4 (Sanjuan et al., 2007), PS-TIM4
(Martinez et al., 2011), and now IgG-
FcgR interactions (Henault et al., 2012).
Impaired LAP in the absence of ATG5,
ATG7, or Beclin-1 converts the silent
phagocytosis of apoptotic cells to inflam-
matory phagocytosis accompanied by
the production of NF-kB-dependent IL-b
and IL-6 and likely due to persistence
of apoptotic cell derived ligands within
phagosomes (Martinez et al., 2011).
Whether TLR9 mediates these responses
is not clear. Notably, defective clearance
of apoptotic cells contributes to the path-
ogenesis of SLE (Elkon and Santer, 2012).
Although Martinez et al. (2011) did not
measure type I IFN responses, one pre-
diction would be that unlike successful
formation of the ‘‘NF-kB phagosome,’’
the ‘‘IRF7 phagolysosome’’ would fail to
form in the absence of LAP, and thusIFN-a would not be made. However, it
may not be that simple. Lack of FcgR
engagement during phagocytosis of
apoptotic cells should prevent TLR9
recruitment in the first place, according
to the data by Henault et al. (2012). Inter-
play between FcgR and TLR9 may thus
serve as a safety measure calling in
TLR9 only upon phagocytosis of anti-
body-opsonized microbial pathogens,
thereby ensuring its delivery to phago-
somes carrying microbial nucleic acids.
Apoptotic cells are usually opsonized by
complement (Elkon and Santer, 2012),
and it will be important to test how
complement receptor (CR) engagement
impacts TLR9 recruitment. The safest
outcome would be that unlike the in-
terplay between FcgR and TLR9, no
communication exists between CR and
TLR9. Alternatively, engagement of TIM4
or other PS receptors during phagocy-
tosis of apoptotic cells may restrain traf-
ficking of nucleic acid responsive TLR,
such as TLR9 and TLR7, from ER to
phagosome.
Coupling signaling from surface re-
ceptors to phagosomal recruitment of
intracellular receptors may be a general
paradigm that relays information about
the internalized cargo and safeguards
against an inappropriate response to
host-derived components. It would, for
example, prepare a phagosome for
mounting a type I IFN response to
microbial DNA and preclude mobiliza-
tion of a response to self-DNA. This ofImmunity 37, Dcourse falls apart, as Henault et al.
(2012) show us here, when pathogenic
autoantibodies are generated to nuclear
DNA in SLE.REFERENCES
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